Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04PVE
|
|||
| Former ID |
DIB016038
|
|||
| Drug Name |
PDA-002
|
|||
| Indication | Diabetic foot ulcer [ICD-11: BD54; ICD-9: 707] | Phase 2 | [1] | |
| Diabetic neuropathy [ICD-11: 8C0Z; ICD-10: G63, G63.2] | Phase 2 | [1] | ||
| Peripheral neuropathy [ICD-11: 8C0Z] | Phase 2 | [2] | ||
| Ulcer [ICD-11: CA02-CB40; ICD-10: K25-K27; ICD-9: 531-534] | Phase 2 | [3] | ||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 3 | ClinicalTrials.gov (NCT02552277) A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.